Form 4: Oracle EVP Sells Shares Under Pre-Arranged 10b5-1 Plan
Insider Transaction Report
Oracle's EVP and Chief Legal Officer, Stuart Levey, sold 19,758 shares of common stock for $300 per share under a pre-arranged 10b5-1 plan.
Summary
- Stuart Levey, Oracle's Executive Vice President and Chief Legal Officer, reported a sale of common stock.
- The transaction involved the disposition of 19,758 shares of Oracle common stock.
- The shares were sold at a price of $300 per share.
- The sale was executed on October 10, 2025.
- Following this transaction, Stuart Levey beneficially owns 18,429 shares of Oracle common stock.
- The sale was made pursuant to a Rule 10b5-1 Plan, which was adopted on July 10, 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly cautious. While insider selling by a key executive can be viewed negatively, the execution under a pre-arranged 10b5-1 plan mitigates the immediate negative implications, suggesting a planned liquidity event rather than a reaction to adverse company-specific news.
Positives
- The transaction was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on immediate, non-public information, which can mitigate negative market interpretations of insider selling.
Negatives
- Stuart Levey, a high-ranking executive (EVP, Chief Legal Officer), sold a significant number of shares (19,758), which could be perceived by some investors as a lack of confidence, despite the pre-planned nature.
Risks
- The sale by a key executive, even if pre-planned, could be misinterpreted by the market as a signal of reduced confidence in the company's future prospects, potentially leading to negative investor sentiment.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Oracle's future performance or outlook.
Industry Context
This is a routine insider transaction filing (Form 4) and does not provide specific insights into broader industry trends or competitive landscape beyond the company's stock activity.
Stakeholder Impact
- Shareholders may interpret the insider sale with slight caution, although the pre-planned nature under a 10b5-1 plan reduces the likelihood of it being seen as a signal of declining company prospects.
Key Dates
| Date | Description |
|---|---|
| 07/10/2025 | Date Rule 10b5-1 Plan was adopted by Stuart Levey. |
| 10/10/2025 | Date of the reported transaction (sale of common stock). |
| 10/14/2025 | Date the Form 4 filing was signed. |
Recommendation
holdWhile the sale of shares by a high-ranking executive could be a minor concern, the transaction was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on immediate, non-public information. This mitigates the negative signal, suggesting a 'hold' position is prudent for existing investors, awaiting further fundamental developments.
Keywords
Oracle, ORCL, insider trading, Form 4, stock sale, Stuart Levey, 10b5-1 plan, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.